Search results
Showing 1 to 50 of 181 results for nice conference
Agency for Care Effectiveness, International Advisory Group (remunerated to NICE) Share options in Legal and General Plc. (remunerated)...
Find out more about supporting a quality standard at NICE.
Ritlecitinib for treating severe alopecia areata in people 12 years and over (TA958)
Evidence-based recommendations on ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years and over.
Early value assessment (EVA) guidance on digital technologies for delivering multidisciplinary weight-management services....
We want you to tell us what matters to you, your organisation or your community.
. Each appeal panel consists of 5 members, 4 of whom are independent of NICE. An external member will chair the appeal panel. This chair...
An advisory service from the UK’s National Institute for Health and Care Excellence to help other countries improve their nation’s health and wellbeing
Developing NICE guidelines: the manual
Biographies and interests register for the indicator advisory committee
This guide describes the methods and processes, including expected timescales, that NICE follows when carrying out health technology evaluations. The methods and processes are designed to produce robust guidance for the NHS in an open, transparent and timely way, with appropriate contribution from stakeholders. Organisations invited to contribute to health technology evaluation development should read this manual in conjunction with the NICE health technology evaluation topic selection: the manual. All documents are available on the NICE website.
Early value assessment (EVA) guidance on artificial intelligence technologies to aid contouring for radiotherapy treatment planning in people having external be...
View recommendations for HTE11Show all sections
Early value assessment (EVA) guidance on guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of ...
How we collect and use your personal information, and your rights under data protection legislation
Apply to the bursary scheme to find out more about how NICE is focusing on what matters most to the health and care system and delivering useful and usable advice, when and where it is most needed.
Ask an expert from NICE International, part of the UK’s National Institute for Health and Care Excellence, to speak at a healthcare event in your country
NICE decision aid: process guide
Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer
Macimorelin for diagnosing growth hormone deficiency (MIB320)
NICE has developed a medtech innovation briefing (MIB) on macimorelin for diagnosing growth hormone deficiency .
Early value assessment is a new evidence-based approach designed to improve the care of people and effective use of NHS resources through quicker access to promising health technologies that address national unmet need. It champions stronger partnership working between regulatory, healthcare and research organisations to benefit people and better support innovators while ensuring value for money for the NHS
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis (IPG746)
Evidence-based recommendations on tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. This involves inserting a catheter under the skin in the abdomen to drain excess fluid when needed, at home or in community care. The aim is to reduce the need for hospital admissions and improve quality of life.
View recommendations for IPG746Show all sections
NICE has developed a medtech innovation briefing (MIB) on digital technologies for the detection of melanoma .
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer (MTG72)
Evidence-based recommendations on Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer.
View recommendations for MTG72Show all sections
NICE has developed a medtech innovation briefing (MIB) on TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failure .
This guideline covers the planning, delivery and review of social work interventions for adults who have complex needs. It promotes ways for social work professionals, other care staff and people with complex needs to work together to make decisions about care and support.
Evidence-based recommendations on niraparib (Zejula) for treating relapsed, platinum-sensitive high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer in adults.
UroShield for preventing catheter-associated urinary tract infections (MTG69)
Evidence-based recommendations on UroShield for preventing catheter-associated urinary tract infections.
View recommendations for MTG69Show all sections
to other NICE resources including Patient experience in adult NHS services overview , Patient Experience in Adult NHS Services CG138 ,...
icobrain ms for active relapsing–remitting multiple sclerosis (MIB291)
NICE has developed a medtech innovation briefing (MIB) on icobrain ms for active relapsing–remitting multiple sclerosis .
A quick guide to recognising and responding to domestic violence and abuse
reflecting the NICE principles of 'patient centred care' and 'personalised package of care and information' (Recommendation 1.4,...
PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)
Evidence-based recommendations on PredictSURE IBD and IBDX for guiding treatment of Crohn’s disease
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules (DG46)
Evidence-based recommendations on EarlyCDT Lung for assessing the risk of lung cancer in solid lung nodules
Agency for Care Effectiveness, International Advisory Group (remunerated to NICE) Share options in Legal and General Plc. (remunerated)...
Agency for Care Effectiveness, International Advisory Group (remunerated to NICE) Share options in Legal and General Plc. (remunerated)...
COVID-19 ready rehabilitation for heart failure: REACH-HF can deliver
uk/reach-hf/ To improve the poor uptake and access to CR in heart failure, NICE (NG106) recommendation 66 states that CR 'should be...
Midostaurin for treating advanced systemic mastocytosis (TA728)
Evidence-based recommendations on midostaurin (Rydapt) for treating advanced systemic mastocytosis in adults.
Refer-to-Pharmacy (R2P) is THE tool that let's hospitals meet one of the requirements of NICE's NG5 Medicines Optimisation guidance...
implementation of all NICE guidance? No Does the example relate to a specific implementation of a specific piece of NICE...
asthma, urinary tract infections and diabetes are managed in accordance with NICE guidelines. Our work looks for triggers in relevant...
Quality standards: process guide
HealthVCF for detecting vertebral compression fractures on CT scans (MIB267)
NICE has developed a medtech innovation briefing (MIB) on HealthVCF for detecting vertebral compression fractures on CT scans .
trublood-prostate for triaging and diagnosing people with prostate cancer symptoms (MIB268)
NICE has developed a medtech innovation briefing (MIB) on trublood-prostate for triaging and diagnosing people with prostate cancer symptoms .
Evidence-based recommendations on percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve. This involves passing a closure device through a catheter to block the area that is leaking.
View recommendations for IPG700Show all sections
KODEX-EPD for cardiac imaging during ablation of arrhythmias (MIB260)
NICE has developed a medtech innovation briefing (MIB) on KODEX-EPD for cardiac imaging during ablation of arrhythmias .
Managing COVID symptoms (including at the end of life) in a prison setting
The aim of this work was to apply NICE guidance for managing COVID-19 to the secure healthcare setting to ensure
Axonics sacral neuromodulation system for faecal incontinence (MIB259)
NICE has developed a medtech innovation briefing (MIB) on Axonics sacral neuromodulation system for faecal incontinence .
NICE has developed a medtech innovation briefing (MIB) on microINR for anticoagulation therapy .
NICE has developed a medtech innovation briefing (MIB) on RenalSense Clarity RMS for acute kidney injury .
Evidence-based recommendations on QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography
reablement in section 1.1 and delivering intermediate care in section 1.6 of the NICE guidance for intermediate care (NG74), can be...